BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeeshan M, Jabeen K, Ali AN, Ali AW, Farooqui SZ, Mehraj V, Zafar A. Evaluation of immune response to Hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. BMC Infect Dis 2007;7:120. [PMID: 17961205 DOI: 10.1186/1471-2334-7-120] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Specialist Panel on Chronic Hepatitis B in the Middle East. A review of chronic hepatitis B epidemiology and management issues in selected countries in the Middle East. J Viral Hepat. 2012;19:9-22. [PMID: 22187943 DOI: 10.1111/j.1365-2893.2011.01511.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
2 Tan EM, Marcelin JR, Virk A. Pre-travel counseling for immunocompromised travelers: A 12-year single-center retrospective review. Infect Dis Health 2019;24:13-22. [PMID: 30541695 DOI: 10.1016/j.idh.2018.09.083] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
3 Zhao Y, Pan L, Hao Z, Jin F, Zhang Y, Li M, Zhang X, Han B, Zhou H, Ma T, Wang F, Ma J, Shen L, Li Q. Immune response to different types of hepatitis B vaccine booster doses 2–32 years after the primary immunization schedule and its influencing factors. International Journal of Infectious Diseases 2020;93:62-7. [DOI: 10.1016/j.ijid.2020.01.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Abd El-Wahab EW, Metwally M, Lotfy N. Effectiveness of hepatitis B vaccination in chronic HCV patients after successful generic direct acting antiviral therapy: significance of isolated hepatitis B core antibodies. Trop Med Int Health 2021;26:882-94. [PMID: 33860608 DOI: 10.1111/tmi.13588] [Reference Citation Analysis]
5 Basireddy P, Avileli S, Beldono N, Gundela SL. Evaluation of immune response to hepatitis B vaccine in healthcare workers at a tertiary care hospital. Indian J Med Microbiol 2018;36:397-400. [PMID: 30429394 DOI: 10.4103/ijmm.IJMM_17_431] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Klein SL. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bioessays. 2012;34:1050-1059. [PMID: 23012250 DOI: 10.1002/bies.201200099] [Cited by in Crossref: 141] [Cited by in F6Publishing: 128] [Article Influence: 15.7] [Reference Citation Analysis]
7 Shim J, Kim KY, Kim BH, Chun H, Lee MS, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers. Vaccine. 2011;29:1721-1726. [PMID: 21147128 DOI: 10.1016/j.vaccine.2010.11.044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gebhard C, Regitz-zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ 2020;11. [DOI: 10.1186/s13293-020-00304-9] [Cited by in Crossref: 307] [Cited by in F6Publishing: 270] [Article Influence: 307.0] [Reference Citation Analysis]
9 Lee BS, Cho YK, Jeong SH, Lee JH, Lee D, Park NH, Ki M; Korean Hepatitis Epidemiology Study Group. Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs. J Med Virol. 2013;85:1327-1333. [PMID: 23723057 DOI: 10.1002/jmv.23594] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
10 Thomas RJ, Fletcher GJ, Kirupakaran H, Chacko MP, Thenmozhi S, Eapen CE, Chandy G, Abraham P. Prevalence of non-responsiveness to an indigenous recombinant hepatitis B vaccine: a study among South Indian health care workers in a tertiary hospital. Indian J Med Microbiol 2015;33 Suppl:32-6. [PMID: 25657153 DOI: 10.4103/0255-0857.150877] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
11 Sahana HV, Sarala N, Prasad SR. Decrease in Anti-HBs Antibodies over Time in Medical Students and Healthcare Workers after Hepatitis B Vaccination. Biomed Res Int 2017;2017:1327492. [PMID: 29082237 DOI: 10.1155/2017/1327492] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
12 Li L, Zhou L, Yu Y, Zhu Z, Lin C, Lu C, Yang R. Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody. Diagn Microbiol Infect Dis 2009;63:165-72. [PMID: 19150709 DOI: 10.1016/j.diagmicrobio.2008.10.020] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
13 Ganczak M, Korzen M, Jurewicz A, Szych Z. A cross-sectional sero-survey on preoperative HBV vaccination policy in Poland. BMC Infect Dis 2017;17:515. [PMID: 28743234 DOI: 10.1186/s12879-017-2607-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Ansari M, Ehrampoush MH, Farzadkia M, Ahmadi E. Dynamic assessment of economic and environmental performance index and generation, composition, environmental and human health risks of hospital solid waste in developing countries; A state of the art of review. Environ Int 2019;132:105073. [PMID: 31421384 DOI: 10.1016/j.envint.2019.105073] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
15 Hada V, Saurabh K, Sharma A, Nag VL, Gadepalli RS, Maurya AK. Nursing students: A vulnerable health-care worker for needlesticks injuries in teaching hospitals. J Family Med Prim Care 2018;7:717-20. [PMID: 30234043 DOI: 10.4103/jfmpc.jfmpc_265_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
16 Zimmermann P, Curtis N. Factors That Influence the Immune Response to Vaccination. Clin Microbiol Rev. 2019;32. [PMID: 30867162 DOI: 10.1128/cmr.00084-18] [Cited by in Crossref: 132] [Cited by in F6Publishing: 74] [Article Influence: 66.0] [Reference Citation Analysis]
17 Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10:338-349. [PMID: 20417416 DOI: 10.1016/s1473-3099(10)70049-9] [Cited by in Crossref: 357] [Cited by in F6Publishing: 231] [Article Influence: 32.5] [Reference Citation Analysis]
18 Trevisan A, Frasson C, De Nuzzo D, Nicolli A, Scapellato ML. Significance of anti-HB levels below 10 IU/L after vaccination against hepatitis B in infancy or adolescence: an update in relation to sex. Hum Vaccin Immunother 2020;16:460-4. [PMID: 31487228 DOI: 10.1080/21645515.2019.1656483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, Xu K, Ren J, Yao J, Li Y, Cao Q, Chen P, Xie T, Wang C, Wang B, Mao C, Ruan B, Jiang T, Li L. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. 2016;6:27251. [PMID: 27324884 DOI: 10.1038/srep27251] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 9.6] [Reference Citation Analysis]
20 Klein SL. Sex differences in prophylaxis and therapeutic treatments for viral diseases. Handb Exp Pharmacol 2012;:499-522. [PMID: 23027464 DOI: 10.1007/978-3-642-30726-3_22] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
21 Chathuranga LS, Noordeen F, Abeykoon AM. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka. Int J Infect Dis 2013;17:e1078-9. [PMID: 23810225 DOI: 10.1016/j.ijid.2013.04.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
22 Zaidi MA, Griffiths R, Beshyah SA, Myers J, Zaidi MA. Blood and body fluid exposure related knowledge, attitude and practices of hospital based health care providers in United arab emirates. Saf Health Work 2012;3:209-15. [PMID: 23019533 DOI: 10.5491/SHAW.2012.3.3.209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
23 Van Den Ende C, Marano C, Van Ahee A, Bunge EM, De Moerlooze L. The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Review of Vaccines 2017;16:811-32. [DOI: 10.1080/14760584.2017.1338568] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
24 Djeriri K, Laurichesse H, Merle JL, Charof R, Abouyoub A, Fontana L, Benchemsi N, Elharti E, El Aouad R, Chamoux A, Beytout J. Hepatitis B in Moroccan health care workers. Occup Med (Lond) 2008;58:419-24. [PMID: 18562546 DOI: 10.1093/occmed/kqn071] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
25 Hudu SA, Malik YA, Niazlin MT, Harmal NS, Adnan A, Alshrari AS, Sekawi Z. Antibody and immune memory persistence post infant hepatitis B vaccination. Patient Prefer Adherence 2013;7:981-6. [PMID: 24101865 DOI: 10.2147/PPA.S49776] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
26 Pan H, Zeng Y, Song X, Zhang Y, Xu K, Liang Z, Zhu F. Immune response to hepatitis B vaccine with high antigen content in non-responders after standard primary vaccination in Chinese adults. Vaccine 2014;32:3706-12. [DOI: 10.1016/j.vaccine.2014.02.094] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
27 McCarty JM, Lock MD, Bennett S, Hunt KM, Simon JK, Gurwith M. Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial. Vaccine 2019;37:1389-97. [PMID: 30772070 DOI: 10.1016/j.vaccine.2019.01.077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
28 Reisler RB, Gibbs PH, Danner DK, Boudreau EF. Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis. Vaccine 2012;30:7271-7. [PMID: 23031498 DOI: 10.1016/j.vaccine.2012.09.049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
29 Muvunyi CM, Harelimana JD, Sebatunzi OR, Atmaprakash AC, Seruyange E, Masaisa F, Manzi O, Nyundo M, Hategekimana T. Hepatitis B vaccination coverage among healthcare workers at a tertiary hospital in Rwanda. BMC Res Notes 2018;11:886. [PMID: 30545400 DOI: 10.1186/s13104-018-4002-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
30 Janssen HLA, Brunetto MR, Kim YJ, Ferrari C, Massetto B, Nguyen AH, Joshi A, Woo J, Lau AH, Gaggar A, Subramanian GM, Yoshida EM, Ahn SH, Tsai NCS, Fung S, Gane EJ. Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. J Hepatol. 2018;68:431-440. [PMID: 29104121 DOI: 10.1016/j.jhep.2017.10.027] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 19.0] [Reference Citation Analysis]
31 Nashibi R, Alavi SM, Yousefi F, Salmanzadeh S, Moogahi S, Ahmadi F, Farashahinejad M. Post-vaccination Immunity Against Hepatitis B Virus and Predictors for Non-responders Among Medical Staff. Jundishapur J Microbiol 2015;8:e19579. [PMID: 25861435 DOI: 10.5812/jjm.19579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
32 Rusnak JM, Gibbs P, Boudreau E, Clizbe DP, Pittman P. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study. Vaccine 2011;29:3222-9. [DOI: 10.1016/j.vaccine.2011.02.037] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
33 Lithgow D, Cole C. A reinvestigation of seroconversion rates in hepatits B-vaccinated individuals. Biol Res Nurs 2015;17:49-54. [PMID: 25504950 DOI: 10.1177/1099800414524619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Erhabor O, Mohammad SY, Bello L, Onuigwe FU, Abdulrahman Y, Zama I, Buhari H, Bagudo A, Ibrahim K, Ahmed M, Udomah FP, Adias TC, Erhabor T, Okara GC. Prevalence of some hepatitis B virus markers among pregnant women attending antenatal clinic in Specialist Hospital Sokoto Nigeria. Hum Antibodies 2020;28:233-43. [PMID: 32333583 DOI: 10.3233/HAB-200412] [Cited by in F6Publishing: 2] [Reference Citation Analysis]